| Product NDC: | 68258-7090 | 
| Proprietary Name: | Zyprexa | 
| Non Proprietary Name: | Olanzapine | 
| Active Ingredient(s): | 2.5 mg/1 & nbsp; Olanzapine | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 68258-7090 | 
| Labeler Name: | Dispensing Solutions, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA020592 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19970623 | 
| Package NDC: | 68258-7090-1 | 
| Package Description: | 14 TABLET in 1 BOTTLE, PLASTIC (68258-7090-1) | 
| NDC Code | 68258-7090-1 | 
| Proprietary Name | Zyprexa | 
| Package Description | 14 TABLET in 1 BOTTLE, PLASTIC (68258-7090-1) | 
| Product NDC | 68258-7090 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Olanzapine | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 19970623 | 
| Marketing Category Name | NDA | 
| Labeler Name | Dispensing Solutions, Inc. | 
| Substance Name | OLANZAPINE | 
| Strength Number | 2.5 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |